Security key
641288105
NeuroPace Inc - Common Stock, $0.01 par value (NPCE)
CUSIP: 641288105
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 14,795,861
- Total 13F value
- $103,125,040
- Share change
- +225,626
- Put/Call ratio
- 7.7%
- SEC-reported price per share
- $6.97
- Number of holders
- 48
- Value change
- +$1,471,249
- Number of buys
- 21
- Number of sells
- 23
- Shares outstanding
- 34,317,804
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
48
Top holders
10
NPCE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
NeuroPace Inc SEC filings
NeuroPace Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 641288105
Recent filing periods:
Ownership snapshot
Top reported holders of NPCE - NeuroPace Inc - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Accelmed Partners II L.P.
Disclosed value leader
Accelmed Partners II L.P.
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $44,878,722
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Accelmed Partners II L.P. has the largest disclosed position value at $44.88M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Accelmed Partners II L.P.'s linked filing trail.
Disclosed position value
Top 5
Accelmed Partners II L.P.
$44.88M
ORBIMED ADVISORS LLC
$25.75M
MORGAN STANLEY
$18.68M
Soleus Capital Management, L.P.
$18.39M
Kent Lake Capital LLC
$8.65M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Accelmed Partners II L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$44,878,722
4,432,948 shares
|
— | 21 Nov 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$25,751,893
3,406,335 shares
|
— | 30 Jun 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$18,681,834
2,471,142 shares
|
— | 30 Jun 2024 |
| Soleus Capital Management, L.P. |
13F
Company
|
—
denominator unverified
|
$18,394,750
2,433,168 shares
|
— | 30 Jun 2024 |
| Kent Lake Capital LLC |
13F
Company
|
—
denominator unverified
|
$8,650,560
1,144,254 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$7,315,933
967,716 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
48
Shares
14,795,861
Rows available
48
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
51
Q3 2024 holders
48
Holder diff
-3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend